BREATHE – Distribution and co-expression of T2 biomarkers in asthma and association with severity, clinical characteristics and co-morbidities

D. Klein (København NV, Denmark), L. Frøssing (København NV, Denmark), G. Telg (Södertälje, Sweden), C. Porsbjerg (København NV, Denmark)

Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Klein (København NV, Denmark), L. Frøssing (København NV, Denmark), G. Telg (Södertälje, Sweden), C. Porsbjerg (København NV, Denmark). BREATHE – Distribution and co-expression of T2 biomarkers in asthma and association with severity, clinical characteristics and co-morbidities. 1102

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of comorbidities on severity and clinical parameters of COPD
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018

Effect of GERD on clinical severity and functional characteristics of lung function in asthma
Source: Annual Congress 2011 - Clinical parameters in airway diseases
Year: 2011

Comparison of comorbidities between two different subgroups in combined assessment of COPD
Source: International Congress 2016 – Postural balance, respiratory muscles, and comorbidities in chronic respiratory disease
Year: 2016

The relationship of comorbidities with clinical and phsyiological parameters in COPD
Source: Annual Congress 2012 - COPD comorbidities II
Year: 2012

Clinical characteristics and related risk factors of depression in patients with early COPD
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018

Distribution of T2 markers in real-life patients with asthma, COPD and asthma+COPD from the BREATHE study
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020


Patient baseline variables predict future asthma control status and risk of exacerbations
Source: Annual Congress 2010 - Management of airway disease
Year: 2010

IPF cluster analysis highlights diagnostic delay and cardiovascular comorbidities association with outcome
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021


Stability of serum biomarkers and their associations with clinical outcomes in COPD patients and controls: a longitudinal study
Source: Annual Congress 2009 - Biomarkers and biology in COPD
Year: 2009


Patient characteristics, biomarkers and exacerbation risk in severe, uncontrolled asthma
Source: Eur Respir J, 58 (6) 2100413; 10.1183/13993003.00413-2021
Year: 2021



Comparison of severity of clinical, functional signs of COPD with the frequency and severity of mental disorders
Source: International Congress 2017 – Extrapulmonary comorbidities in COPD
Year: 2017


Prevalence and clinical relevance of comorbidities in IPF
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018

Using characteristics of asthma phenotypes to determine exacerbation severity
Source: Virtual Congress 2020 – Phenotypes of obstructive diseases
Year: 2020


Comparison of functionality and symptoms in COPD patients with different nutritional status
Source: International Congress 2016 – Treatment and assessment of functional outcomes in cardiorespiratory physiotherapy
Year: 2016


Correlation between fever and clinical severity in bronchiolitis - is there an influence of associated risk factors?
Source: Annual Congress 2004 - Viral bronchiolitis in children: what's new in diagnosis and treatment?
Year: 2004


COPD related fatigue (COPD-RF) as a patient centred outcome tool in COPD: Various predictors and its correlation with other outcome parameters
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016


Asthma phenotyping: Correlation between inflammatory phenotype, clinical parameters and associated comorbidities
Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases
Year: 2012

Clinical features and factors associated current smoking in stage I COPD
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020


Correlation between indices of quality of life and degree of severity of symptoms in patients with asthma in combination with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 520s
Year: 2004

Correlation between red cell distribution width and disease severity and mortality in COPD patients
Source: International Congress 2014 – COPD exacerbations
Year: 2014